Biomarkers correlate with colon cancer and risks: A preliminary study

Diseases of the Colon and Rectum

Volumn 52, Issue 4, 2009, Pages 715-724

  Lu, Shan ^a   Chiu, Yanek S Y ^a   Smith, Andrew P ^a   Moore, Dan ^a   Lee, Nancy M ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Real time reverse transcription polymerase chain reaction; Rectal swab

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; COLONY STIMULATING FACTOR 1; CYCLIN D; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HERMES ANTIGEN; INTERLEUKIN 8; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; SERUM AMYLOID A; SERUM AMYLOID A1; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; COLON CANCER; COLON POLYP; COLONOSCOPY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GROWTH RELATED ONCOGENE ALPHA; GROWTH RELATED ONCOGENE GAMMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MUCOSA CELL; NON INVASIVE PROCEDURE; ONCOGENE; ONCOGENE C MYC; REAL TIME POLYMERASE CHAIN REACTION; RECTUM BIOPSY; RECTUM MUCOSA; RECTUM SWAB; SELF REPORT; BIOPSY; COLON TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; INTESTINE MUCOSA; LABORATORY DIAGNOSIS; METABOLISM; MULTIVARIATE ANALYSIS; PRECANCER; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BIOPSY; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTESTINAL MUCOSA; MALE; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 66849103940     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819ed196     Document Type: Article

References (35)

1. Day DW, Morson BC. The adenoma-carcinoma sequence. Major Probl Pathol 1978;10:58Y71.
2. Ransohoff DF. Colon cancer screening in 2005: status and challenges. Gastroeneterology 2005;128:1685Y96.
3. Powell SM, Zilz N, Beaser-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359: 235Y7.
4. Pretlow TP, Brasitus TA, Fulton NC, et al. K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 1993;85:2004Y7.
5. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998;58:1130Y4.
6. Ieda S, Watatani M, Yoshida T, et al. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas. Surg Today 1996;26:230Y5.
7. Mosnier JF, Perret AG, Vindimian M, et al. An immunohistochemical study of the simultaneousf expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 1996;120:654Y9.
8. Iino H, Jass JR, Simms LA, et al. DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol 1999;52:5Y9.
9. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 2000;37:295Y301.
10. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192Y206.
11. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219Y27.
12. Dong SM, Traverso G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001;93:858Y65.
13. Koshiji M, Yonekura Y, Saito T, et al. Microsatellite analysis of fecal DNA for colorectal cancer detection. J Surg Oncol 2002;80:34Y40.
14. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311Y20.
15. Berger BM, Vucson BM, Diteberg JS. Gene mutations in advanced colonic polyps: potential marker selection for stoolbased mutated human DNA assays for colon cancer screening. Clin Colorectal Cancer 2003;3:180Y5.
16. Calistri D, Rengucci C, Bocchini R, et al. Fecal multiple molecular tests to detect colorectal cancer in stool. Clin Gastroenterol Hepatol 2003;1:377Y83.
17. Tagore KS, Lawson MJ, Yucaitis JA, et al. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clin Colorectal Cancer 2003;3:47Y53.
18. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704Y14.
19. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001;159:1231Y8.
20. Baron A, Moore PS, Scarpa A. DNA array/microarrays in oncological research with focus on pancreatic cancer. Adv Clin Path 2001;5:115Y20.
21. Hsu CN, Lai JM, Liu CH, et al. Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics 2007;8:66.
22. Juric D, Lacayo NJ, Ramsey MC, et al. Differential gene expression patterns and interaction networks in BCR-ABLpositive and -negative adult acute lymphoblastic leukemias. J Clin Oncol 2007;25:1341Y9.
23. Bartman AE, Sanderson SJ, Ewing SL, et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 1999;80:210Y8.
24. Buckhaults P, Rago C, St Croix B, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996Y7001.
25. Notterman DA, Alon U, Sierk AJ, et al. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124Y30.
26. Chen LC, Hao CY, Chiu YS, et al. Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res 2004;64: 3694Y700.
27. Sugiyama Y, Farrow B, Murillo C, et al. Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 2005;128:480Y6.
28. Hao CY, Moore DH, Wong P, et al. Alteration of gene expression in macroscopically normal colonic mucosa from individuals with a family history of sporadic colon cancer. Clin Cancer Res 2005;11:1400Y7.
29. Hao CY, Moore DH, Chiu YS, et al. Altered gene expression in normal colonic mucosa of individuals with polyps of the colon. Dis Colon Rectum 2005;48:2329Y35.
30. Polley AC, Mulholland F, Pin C, et al. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res 2006;66:6653Y62.
31. Ahmed FE, Vos P, James S, et al. Transcriptomic molecular markers for screening human colon cancer in stool and tissue. Cancer Genomics Proteomics 2007;4:1Y20.
32. Mahalanobis PC. On the generalized distance in statistics. Proc Natl Inst Sci India 1936;12:49Y55.
33. Jonsson PF, Cavanna T, Zicha D, et al. Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis. BMC Bioinformatics 2006;7:2.
34. Platzer A, Perco P, Lukas A, et al. Characterization of protein interaction networks in tumors. BMC Bioinformatics 2007;8:224.
35. Chiang JH, Chao SY. Modeling human cancer-related regulatory modules by GA-RNN hybrid algorithms. BMC Informatics 2007;8:91.